

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proline biosynthetic process (GO:0006561) | 9.60850782 |
| 2 | primary alcohol catabolic process (GO:0034310) | 9.32529681 |
| 3 | exploration behavior (GO:0035640) | 8.94378718 |
| 4 | muscle filament sliding (GO:0030049) | 8.51309038 |
| 5 | actin-myosin filament sliding (GO:0033275) | 8.51309038 |
| 6 | ethanol metabolic process (GO:0006067) | 8.34071595 |
| 7 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 8.02875430 |
| 8 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 8.02875430 |
| 9 | skeletal muscle contraction (GO:0003009) | 7.23857693 |
| 10 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 7.20016383 |
| 11 | regulation of necrotic cell death (GO:0010939) | 7.14756706 |
| 12 | hepatocyte apoptotic process (GO:0097284) | 7.00882559 |
| 13 | actin-mediated cell contraction (GO:0070252) | 6.75455435 |
| 14 | intestinal epithelial cell development (GO:0060576) | 6.71557449 |
| 15 | proline metabolic process (GO:0006560) | 6.67978176 |
| 16 | endocrine pancreas development (GO:0031018) | 6.46932253 |
| 17 | regulation of respiratory burst (GO:0060263) | 6.38876111 |
| 18 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 6.34762889 |
| 19 | regulation of MHC class I biosynthetic process (GO:0045343) | 6.32213258 |
| 20 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 6.31570065 |
| 21 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.25875486 |
| 22 | acylglycerol homeostasis (GO:0055090) | 6.22090460 |
| 23 | triglyceride homeostasis (GO:0070328) | 6.22090460 |
| 24 | cell differentiation involved in embryonic placenta development (GO:0060706) | 6.05905191 |
| 25 | positive regulation of glucose transport (GO:0010828) | 6.03395702 |
| 26 | purine deoxyribonucleotide catabolic process (GO:0009155) | 6.00720660 |
| 27 | regulation of skeletal muscle contraction (GO:0014819) | 5.88797755 |
| 28 | regulation of substrate adhesion-dependent cell spreading (GO:1900024) | 5.87592234 |
| 29 | regulation of cAMP-mediated signaling (GO:0043949) | 5.84050261 |
| 30 | phosphatidylglycerol biosynthetic process (GO:0006655) | 5.73227165 |
| 31 | natural killer cell activation involved in immune response (GO:0002323) | 5.67380209 |
| 32 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.32068614 |
| 33 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 5.26718384 |
| 34 | cellular response to type I interferon (GO:0071357) | 5.24262300 |
| 35 | type I interferon signaling pathway (GO:0060337) | 5.24262300 |
| 36 | response to type I interferon (GO:0034340) | 5.14854169 |
| 37 | actin filament-based movement (GO:0030048) | 5.11713304 |
| 38 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 5.08167361 |
| 39 | positive regulation of digestive system process (GO:0060456) | 5.07044619 |
| 40 | immunoglobulin mediated immune response (GO:0016064) | 5.03696805 |
| 41 | galactose catabolic process (GO:0019388) | 4.98321045 |
| 42 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.94908610 |
| 43 | positive regulation of protein homooligomerization (GO:0032464) | 4.71418607 |
| 44 | negative regulation of glial cell proliferation (GO:0060253) | 4.66701420 |
| 45 | glutamine family amino acid biosynthetic process (GO:0009084) | 4.64837768 |
| 46 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 4.61005270 |
| 47 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 4.59133468 |
| 48 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.58171992 |
| 49 | trophectodermal cell differentiation (GO:0001829) | 4.53906640 |
| 50 | deoxyribonucleotide catabolic process (GO:0009264) | 4.49354560 |
| 51 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.49007706 |
| 52 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.42818202 |
| 53 | striated muscle contraction (GO:0006941) | 4.39322191 |
| 54 | cellular response to exogenous dsRNA (GO:0071360) | 4.33540448 |
| 55 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.32220688 |
| 56 | skeletal muscle fiber development (GO:0048741) | 4.26596230 |
| 57 | cellular response to interferon-beta (GO:0035458) | 4.22562830 |
| 58 | lung secretory cell differentiation (GO:0061140) | 4.20642799 |
| 59 | potassium ion export (GO:0071435) | 4.19314531 |
| 60 | long-term synaptic potentiation (GO:0060291) | 4.18390970 |
| 61 | myofibril assembly (GO:0030239) | 4.13471153 |
| 62 | purine nucleotide salvage (GO:0032261) | 4.11824498 |
| 63 | positive regulation of insulin secretion (GO:0032024) | 4.11441737 |
| 64 | deoxyribose phosphate catabolic process (GO:0046386) | 4.07995389 |
| 65 | labyrinthine layer development (GO:0060711) | 4.07201993 |
| 66 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 4.06923676 |
| 67 | creatine metabolic process (GO:0006600) | 4.05181463 |
| 68 | defense response to protozoan (GO:0042832) | 4.04210422 |
| 69 | membrane repolarization during action potential (GO:0086011) | 4.00874700 |
| 70 | ATP synthesis coupled proton transport (GO:0015986) | 4.00062433 |
| 71 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.00062433 |
| 72 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.98521664 |
| 73 | regulation of relaxation of muscle (GO:1901077) | 3.93869254 |
| 74 | negative regulation of myotube differentiation (GO:0010832) | 3.93163203 |
| 75 | positive regulation of antigen processing and presentation (GO:0002579) | 3.90025099 |
| 76 | cellular response to virus (GO:0098586) | 3.88109812 |
| 77 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.87645013 |
| 78 | Peyers patch development (GO:0048541) | 3.84645832 |
| 79 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.84645832 |
| 80 | placenta development (GO:0001890) | 3.81502609 |
| 81 | positive regulation of interferon-alpha production (GO:0032727) | 3.81226821 |
| 82 | response to inactivity (GO:0014854) | 3.78968257 |
| 83 | positive thymic T cell selection (GO:0045059) | 3.78364807 |
| 84 | mitochondrial calcium ion transport (GO:0006851) | 3.74560637 |
| 85 | histamine secretion (GO:0001821) | 3.69959132 |
| 86 | intestinal absorption (GO:0050892) | 3.69211632 |
| 87 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.67873344 |
| 88 | regulation of germinal center formation (GO:0002634) | 3.67650319 |
| 89 | positive regulation of myotube differentiation (GO:0010831) | 3.67602634 |
| 90 | GDP-mannose metabolic process (GO:0019673) | 3.67234567 |
| 91 | B cell mediated immunity (GO:0019724) | 3.66825850 |
| 92 | regulation of G0 to G1 transition (GO:0070316) | 3.65336792 |
| 93 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.64442755 |
| 94 | cardiovascular system development (GO:0072358) | 3.63966413 |
| 95 | response to axon injury (GO:0048678) | 3.62883865 |
| 96 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.60230584 |
| 97 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.58457476 |
| 98 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.57668721 |
| 99 | negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124) | 3.57472128 |
| 100 | low-density lipoprotein particle remodeling (GO:0034374) | 3.56519848 |
| 101 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.55854051 |
| 102 | myotube cell development (GO:0014904) | 3.55513120 |
| 103 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.53608610 |
| 104 | atrial cardiac muscle cell action potential (GO:0086014) | 3.50683194 |
| 105 | response to protozoan (GO:0001562) | 3.49952650 |
| 106 | regulation of interferon-alpha production (GO:0032647) | 3.48777437 |
| 107 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.47210114 |
| 108 | regulation of growth of symbiont in host (GO:0044126) | 3.47210114 |
| 109 | negative regulation of growth of symbiont in host (GO:0044130) | 3.47210114 |
| 110 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.47210114 |
| 111 | keratinocyte development (GO:0003334) | 3.47060187 |
| 112 | sarcomere organization (GO:0045214) | 3.46982586 |
| 113 | glandular epithelial cell differentiation (GO:0002067) | 3.46300296 |
| 114 | regulation of penile erection (GO:0060405) | 3.45546267 |
| 115 | regulation of transcription initiation from RNA polymerase II promoter (GO:0060260) | 3.41187745 |
| 116 | muscle cell fate commitment (GO:0042693) | 3.40697367 |
| 117 | decidualization (GO:0046697) | 3.40255858 |
| 118 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.38735284 |
| 119 | galactose metabolic process (GO:0006012) | 3.38684375 |
| 120 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.38546458 |
| 121 | pyrimidine-containing compound salvage (GO:0008655) | 3.36942529 |
| 122 | pyrimidine nucleoside salvage (GO:0043097) | 3.36942529 |
| 123 | NADH metabolic process (GO:0006734) | 3.36872393 |
| 124 | muscle contraction (GO:0006936) | 3.34496054 |
| 125 | L-serine transport (GO:0015825) | 3.33244544 |
| 126 | nucleotide salvage (GO:0043173) | 3.32419853 |
| 127 | response to muscle activity (GO:0014850) | 3.31420161 |
| 128 | bone morphogenesis (GO:0060349) | 3.30471298 |
| 129 | skeletal muscle tissue regeneration (GO:0043403) | 3.29720982 |
| 130 | skeletal muscle tissue development (GO:0007519) | 3.28873273 |
| 131 | positive regulation of peptide hormone secretion (GO:0090277) | 3.27466612 |
| 132 | negative regulation of B cell apoptotic process (GO:0002903) | 3.25636160 |
| 133 | phosphatidylserine metabolic process (GO:0006658) | 3.24156772 |
| 134 | negative thymic T cell selection (GO:0045060) | 3.23924222 |
| 135 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.23733923 |
| 136 | thymic T cell selection (GO:0045061) | 3.21726770 |
| 137 | Golgi transport vesicle coating (GO:0048200) | 3.17329604 |
| 138 | COPI coating of Golgi vesicle (GO:0048205) | 3.17329604 |
| 139 | regulation of hypersensitivity (GO:0002883) | 3.16447463 |
| 140 | desmosome organization (GO:0002934) | 3.16197676 |
| 141 | positive regulation of peptide secretion (GO:0002793) | 3.16045902 |
| 142 | cardiac conduction (GO:0061337) | 3.15884313 |
| 143 | positive regulation of gastrulation (GO:2000543) | 3.13886035 |
| 144 | growth hormone secretion (GO:0030252) | 3.13124311 |
| 145 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.10825832 |
| 146 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.07249253 |
| 147 | plasma membrane repair (GO:0001778) | 3.07145611 |
| 148 | histamine transport (GO:0051608) | 3.05951175 |
| 149 | 2-oxoglutarate metabolic process (GO:0006103) | 3.04017935 |
| 150 | muscle system process (GO:0003012) | 3.03307872 |
| 151 | mature B cell differentiation involved in immune response (GO:0002313) | 3.03305865 |
| 152 | regulation of phagocytosis (GO:0050764) | 3.02706753 |
| 153 | positive regulation of neutrophil migration (GO:1902624) | 2.98927621 |
| 154 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.98927621 |
| 155 | skeletal muscle adaptation (GO:0043501) | 2.92137984 |
| 156 | adenosine metabolic process (GO:0046085) | 2.91938514 |
| 157 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.91478785 |
| 158 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.91337596 |
| 159 | response to host immune response (GO:0052572) | 2.91337596 |
| 160 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.90933690 |
| 161 | establishment of viral latency (GO:0019043) | 2.90038035 |
| 162 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.89694527 |
| 163 | response to interferon-beta (GO:0035456) | 2.89425137 |
| 164 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.88751816 |
| 165 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.88626630 |
| 166 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 2.88297456 |
| 167 | negative T cell selection (GO:0043383) | 2.87962046 |
| 168 | positive regulation of pseudopodium assembly (GO:0031274) | 2.86781645 |
| 169 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.85744727 |
| 170 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.85226740 |
| 171 | negative regulation of type 2 immune response (GO:0002829) | 2.84860675 |
| 172 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.84741559 |
| 173 | regulation of antigen processing and presentation (GO:0002577) | 2.84657042 |
| 174 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.84077604 |
| 175 | serine transport (GO:0032329) | 2.83592085 |
| 176 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.83262270 |
| 177 | cellular response to epinephrine stimulus (GO:0071872) | 2.81466520 |
| 178 | primary alcohol metabolic process (GO:0034308) | 2.81229550 |
| 179 | gap junction assembly (GO:0016264) | 2.80333247 |
| 180 | regulation of keratinocyte proliferation (GO:0010837) | 2.78751763 |
| 181 | eyelid development in camera-type eye (GO:0061029) | 2.77224600 |
| 182 | positive regulation of chemokine secretion (GO:0090197) | 2.76773361 |
| 183 | diol metabolic process (GO:0034311) | 2.75783148 |
| 184 | bile acid and bile salt transport (GO:0015721) | 2.74279079 |
| 185 | head development (GO:0060322) | 2.72950638 |
| 186 | negative regulation of anoikis (GO:2000811) | 2.70447601 |
| 187 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.68508797 |
| 188 | positive regulation of establishment of protein localization to plasma membrane (GO:0090004) | 2.67881630 |
| 189 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.65286347 |
| 190 | regulation of glial cell proliferation (GO:0060251) | 2.60482761 |
| 191 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.59851438 |
| 192 | alditol phosphate metabolic process (GO:0052646) | 2.58327766 |
| 193 | positive regulation of growth hormone secretion (GO:0060124) | 2.57916703 |
| 194 | regulation of interleukin-8 secretion (GO:2000482) | 2.56797682 |
| 195 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.55923189 |
| 196 | regulation of cellular extravasation (GO:0002691) | 12.2723149 |
| 197 | positive regulation of cAMP-mediated signaling (GO:0043950) | 10.4876221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.49962799 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.49466288 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.42420983 |
| 4 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.77188721 |
| 5 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.23703300 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.73436895 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.27398089 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.87906642 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.81492493 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 2.78636204 |
| 11 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.75212346 |
| 12 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.62693921 |
| 13 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.59585483 |
| 14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.56879288 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.53461193 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.43561479 |
| 17 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 2.38387893 |
| 18 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.35578812 |
| 19 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.31173021 |
| 20 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.30411854 |
| 21 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.27301359 |
| 22 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 2.25255642 |
| 23 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.24437467 |
| 24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.21590449 |
| 25 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.21535677 |
| 26 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.19013946 |
| 27 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.15006292 |
| 28 | UTX_26944678_Chip-Seq_JUKART_Human | 2.13042879 |
| 29 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.09044002 |
| 30 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.06892942 |
| 31 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 2.02506633 |
| 32 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.00419383 |
| 33 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.98243902 |
| 34 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94665191 |
| 35 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.94459468 |
| 36 | * MAF_26560356_Chip-Seq_TH1_Human | 1.89282256 |
| 37 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.86460603 |
| 38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.85874907 |
| 39 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.84234389 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.84073269 |
| 41 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.79016072 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.75009813 |
| 43 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.74342151 |
| 44 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.74264293 |
| 45 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.74015157 |
| 46 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.72131316 |
| 47 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.71895057 |
| 48 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.68827814 |
| 49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68276970 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.67710205 |
| 51 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.63752739 |
| 52 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.63647420 |
| 53 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.63292929 |
| 54 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.62059207 |
| 55 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.61912308 |
| 56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.61419357 |
| 57 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.60998323 |
| 58 | * P68_20966046_ChIP-Seq_HELA_Human | 1.60228024 |
| 59 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.59260171 |
| 60 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.57306367 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57262311 |
| 62 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.57044128 |
| 63 | MAF_26560356_Chip-Seq_TH2_Human | 1.56240334 |
| 64 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.55527687 |
| 65 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.55122666 |
| 66 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.54587839 |
| 67 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.52690433 |
| 68 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.50620100 |
| 69 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.45019454 |
| 70 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.43241995 |
| 71 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.43239217 |
| 72 | SPI1_23127762_ChIP-Seq_K562_Human | 1.43082808 |
| 73 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.42913138 |
| 74 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.42784195 |
| 75 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.41847380 |
| 76 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40828641 |
| 77 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.40583518 |
| 78 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.40281098 |
| 79 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.40140946 |
| 80 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.39781530 |
| 81 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.38806507 |
| 82 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38749572 |
| 83 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.37515265 |
| 84 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.36310097 |
| 85 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.36199927 |
| 86 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.35316919 |
| 87 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.32825758 |
| 88 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.32253108 |
| 89 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.31428292 |
| 90 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.31343644 |
| 91 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.30500538 |
| 92 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.29762754 |
| 93 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.28512677 |
| 94 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.27670121 |
| 95 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27637134 |
| 96 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.27198267 |
| 97 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.26529527 |
| 98 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26127841 |
| 99 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.26114901 |
| 100 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.25861816 |
| 101 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.25388658 |
| 102 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.25027188 |
| 103 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25012497 |
| 104 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.22340627 |
| 105 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.19171606 |
| 106 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.18121187 |
| 107 | MYB_26560356_Chip-Seq_TH2_Human | 1.17117697 |
| 108 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.16297268 |
| 109 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.16297268 |
| 110 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.16248349 |
| 111 | P300_27268052_Chip-Seq_Bcells_Human | 1.15952341 |
| 112 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15042325 |
| 113 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14229613 |
| 114 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.14016385 |
| 115 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.13641325 |
| 116 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13623099 |
| 117 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13256315 |
| 118 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.13198489 |
| 119 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 1.13173587 |
| 120 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.13021569 |
| 121 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.12168463 |
| 122 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.12089517 |
| 123 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.11914456 |
| 124 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.10777550 |
| 125 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.10249586 |
| 126 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10172904 |
| 127 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.09889669 |
| 128 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.09655477 |
| 129 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.07012402 |
| 130 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.07012402 |
| 131 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06186280 |
| 132 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.06036714 |
| 133 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05982850 |
| 134 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.05353617 |
| 135 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.04963412 |
| 136 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.04680039 |
| 137 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.03405825 |
| 138 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.03017511 |
| 139 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.03013926 |
| 140 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.01614295 |
| 141 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.00153638 |
| 142 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.99516133 |
| 143 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.98290801 |
| 144 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96812532 |
| 145 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.96545310 |
| 146 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.95658608 |
| 147 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.95143553 |
| 148 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.95121684 |
| 149 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.94943451 |
| 150 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.94067598 |
| 151 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.93602440 |
| 152 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.92991259 |
| 153 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.92022200 |
| 154 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.91541817 |
| 155 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91189654 |
| 156 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.90087973 |
| 157 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.89993893 |
| 158 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.89600928 |
| 159 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.89510079 |
| 160 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89290153 |
| 161 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.88250237 |
| 162 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.87884701 |
| 163 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87774086 |
| 164 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87610891 |
| 165 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.87129496 |
| 166 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.86536030 |
| 167 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.85926580 |
| 168 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.85584493 |
| 169 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.85304673 |
| 170 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.82535837 |
| 171 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.82167829 |
| 172 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.81786695 |
| 173 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.81307094 |
| 174 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.80754346 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001873_stomach_inflammation | 7.54876193 |
| 2 | MP0003123_paternal_imprinting | 7.12391254 |
| 3 | MP0005451_abnormal_body_composition | 5.64347864 |
| 4 | MP0004264_abnormal_extraembryonic_tissu | 5.14442228 |
| 5 | MP0004145_abnormal_muscle_electrophysio | 5.10955311 |
| 6 | MP0000751_myopathy | 4.70102012 |
| 7 | MP0008004_abnormal_stomach_pH | 4.18923283 |
| 8 | MP0003646_muscle_fatigue | 4.10885429 |
| 9 | MP0000749_muscle_degeneration | 4.05561461 |
| 10 | MP0003787_abnormal_imprinting | 3.96804471 |
| 11 | MP0001663_abnormal_digestive_system | 3.34638214 |
| 12 | MP0004036_abnormal_muscle_relaxation | 3.14700873 |
| 13 | MP0000490_abnormal_crypts_of | 3.07027088 |
| 14 | MP0002106_abnormal_muscle_physiology | 3.02771506 |
| 15 | MP0001346_abnormal_lacrimal_gland | 2.96571812 |
| 16 | MP0003121_genomic_imprinting | 2.92188661 |
| 17 | MP0000537_abnormal_urethra_morphology | 2.89673657 |
| 18 | MP0000759_abnormal_skeletal_muscle | 2.88343201 |
| 19 | MP0004087_abnormal_muscle_fiber | 2.82084216 |
| 20 | MP0002163_abnormal_gland_morphology | 2.77768020 |
| 21 | MP0000747_muscle_weakness | 2.74895025 |
| 22 | MP0005381_digestive/alimentary_phenotyp | 2.66403305 |
| 23 | MP0000462_abnormal_digestive_system | 2.65520621 |
| 24 | MP0001835_abnormal_antigen_presentation | 2.62025699 |
| 25 | MP0005369_muscle_phenotype | 2.59088630 |
| 26 | MP0000013_abnormal_adipose_tissue | 2.56049773 |
| 27 | MP0010234_abnormal_vibrissa_follicle | 2.49574673 |
| 28 | MP0001666_abnormal_nutrient_absorption | 2.45768057 |
| 29 | MP0000750_abnormal_muscle_regeneration | 2.41157640 |
| 30 | MP0002269_muscular_atrophy | 2.35002946 |
| 31 | MP0006054_spinal_hemorrhage | 2.34616152 |
| 32 | MP0003866_abnormal_defecation | 2.30085818 |
| 33 | MP0003122_maternal_imprinting | 2.26438520 |
| 34 | MP0005360_urolithiasis | 2.24288837 |
| 35 | MP0010155_abnormal_intestine_physiology | 2.24154974 |
| 36 | MP0010352_gastrointestinal_tract_polyps | 2.13435602 |
| 37 | MP0004084_abnormal_cardiac_muscle | 2.11967623 |
| 38 | MP0005330_cardiomyopathy | 1.99711526 |
| 39 | MP0005620_abnormal_muscle_contractility | 1.97433244 |
| 40 | MP0003705_abnormal_hypodermis_morpholog | 1.94213852 |
| 41 | MP0006036_abnormal_mitochondrial_physio | 1.93839934 |
| 42 | MP0002332_abnormal_exercise_endurance | 1.89220703 |
| 43 | MP0002139_abnormal_hepatobiliary_system | 1.87253829 |
| 44 | MP0000477_abnormal_intestine_morphology | 1.83566528 |
| 45 | MP0001485_abnormal_pinna_reflex | 1.73297250 |
| 46 | MP0003806_abnormal_nucleotide_metabolis | 1.73140988 |
| 47 | MP0000733_abnormal_muscle_development | 1.64353513 |
| 48 | MP0001800_abnormal_humoral_immune | 1.63543026 |
| 49 | MP0005025_abnormal_response_to | 1.63157104 |
| 50 | MP0002108_abnormal_muscle_morphology | 1.58168094 |
| 51 | MP0002909_abnormal_adrenal_gland | 1.55914491 |
| 52 | MP0000685_abnormal_immune_system | 1.55675716 |
| 53 | MP0004272_abnormal_basement_membrane | 1.51769342 |
| 54 | MP0001664_abnormal_digestion | 1.50440637 |
| 55 | MP0000003_abnormal_adipose_tissue | 1.50224529 |
| 56 | MP0005187_abnormal_penis_morphology | 1.48717456 |
| 57 | MP0008438_abnormal_cutaneous_collagen | 1.46449720 |
| 58 | MP0003300_gastrointestinal_ulcer | 1.38704089 |
| 59 | MP0009278_abnormal_bone_marrow | 1.34954288 |
| 60 | MP0004130_abnormal_muscle_cell | 1.34609051 |
| 61 | MP0005000_abnormal_immune_tolerance | 1.33981645 |
| 62 | MP0003566_abnormal_cell_adhesion | 1.32626638 |
| 63 | MP0010630_abnormal_cardiac_muscle | 1.31884724 |
| 64 | MP0003763_abnormal_thymus_physiology | 1.30254231 |
| 65 | MP0002723_abnormal_immune_serum | 1.28452655 |
| 66 | MP0004019_abnormal_vitamin_homeostasis | 1.27115660 |
| 67 | MP0005266_abnormal_metabolism | 1.26044805 |
| 68 | MP0002148_abnormal_hypersensitivity_rea | 1.22786600 |
| 69 | MP0002796_impaired_skin_barrier | 1.22552730 |
| 70 | MP0005085_abnormal_gallbladder_physiolo | 1.21115772 |
| 71 | MP0002452_abnormal_antigen_presenting | 1.20511972 |
| 72 | MP0002972_abnormal_cardiac_muscle | 1.20480677 |
| 73 | MP0005464_abnormal_platelet_physiology | 1.18993923 |
| 74 | MP0002420_abnormal_adaptive_immunity | 1.18246658 |
| 75 | MP0002419_abnormal_innate_immunity | 1.18207942 |
| 76 | MP0003868_abnormal_feces_composition | 1.17244102 |
| 77 | MP0001348_abnormal_lacrimal_gland | 1.16727076 |
| 78 | MP0005379_endocrine/exocrine_gland_phen | 1.16387792 |
| 79 | MP0002086_abnormal_extraembryonic_tissu | 1.16227595 |
| 80 | MP0001819_abnormal_immune_cell | 1.15399793 |
| 81 | MP0009643_abnormal_urine_homeostasis | 1.14098804 |
| 82 | MP0003724_increased_susceptibility_to | 1.14085733 |
| 83 | MP0003693_abnormal_embryo_hatching | 1.13002776 |
| 84 | MP0004233_abnormal_muscle_weight | 1.12395158 |
| 85 | MP0002398_abnormal_bone_marrow | 1.12256896 |
| 86 | MP0002254_reproductive_system_inflammat | 1.09399982 |
| 87 | MP0003303_peritoneal_inflammation | 1.08862417 |
| 88 | MP0004957_abnormal_blastocyst_morpholog | 1.08481001 |
| 89 | MP0002837_dystrophic_cardiac_calcinosis | 1.03950462 |
| 90 | MP0000716_abnormal_immune_system | 1.02500056 |
| 91 | MP0009785_altered_susceptibility_to | 1.01826874 |
| 92 | MP0008872_abnormal_physiological_respon | 1.01306773 |
| 93 | MP0006138_congestive_heart_failure | 1.00597079 |
| 94 | MP0005076_abnormal_cell_differentiation | 0.99617107 |
| 95 | MP0003879_abnormal_hair_cell | 0.97773505 |
| 96 | MP0005332_abnormal_amino_acid | 0.96773698 |
| 97 | MP0003436_decreased_susceptibility_to | 0.95079543 |
| 98 | MP0001756_abnormal_urination | 0.94726586 |
| 99 | MP0005375_adipose_tissue_phenotype | 0.94583867 |
| 100 | MP0008469_abnormal_protein_level | 0.94327532 |
| 101 | MP0006082_CNS_inflammation | 0.93900357 |
| 102 | MP0000689_abnormal_spleen_morphology | 0.93529674 |
| 103 | MP0000372_irregular_coat_pigmentation | 0.92719226 |
| 104 | MP0003252_abnormal_bile_duct | 0.90813372 |
| 105 | MP0005164_abnormal_response_to | 0.90725793 |
| 106 | MP0008961_abnormal_basal_metabolism | 0.90689230 |
| 107 | MP0003567_abnormal_fetal_cardiomyocyte | 0.90166724 |
| 108 | MP0002429_abnormal_blood_cell | 0.88263838 |
| 109 | MP0004883_abnormal_blood_vessel | 0.87985323 |
| 110 | MP0002722_abnormal_immune_system | 0.87207774 |
| 111 | MP0005365_abnormal_bile_salt | 0.86352213 |
| 112 | MP0004215_abnormal_myocardial_fiber | 0.86329455 |
| 113 | MP0002166_altered_tumor_susceptibility | 0.85603413 |
| 114 | MP0005319_abnormal_enzyme/_coenzyme | 0.85488337 |
| 115 | MP0003453_abnormal_keratinocyte_physiol | 0.85136279 |
| 116 | MP0001944_abnormal_pancreas_morphology | 0.84754177 |
| 117 | MP0002693_abnormal_pancreas_physiology | 0.84021971 |
| 118 | MP0004185_abnormal_adipocyte_glucose | 0.83676913 |
| 119 | MP0001849_ear_inflammation | 0.83376519 |
| 120 | MP0002138_abnormal_hepatobiliary_system | 0.82698214 |
| 121 | MP0003315_abnormal_perineum_morphology | 0.81375161 |
| 122 | MP0002127_abnormal_cardiovascular_syste | 0.79690719 |
| 123 | MP0005666_abnormal_adipose_tissue | 0.78539902 |
| 124 | MP0005387_immune_system_phenotype | 0.78152340 |
| 125 | MP0001790_abnormal_immune_system | 0.78152340 |
| 126 | MP0005671_abnormal_response_to | 0.77934720 |
| 127 | MP0002877_abnormal_melanocyte_morpholog | 0.77904851 |
| 128 | MP0005058_abnormal_lysosome_morphology | 0.76769700 |
| 129 | MP0009840_abnormal_foam_cell | 0.75818183 |
| 130 | MP0000470_abnormal_stomach_morphology | 0.75641508 |
| 131 | MP0003828_pulmonary_edema | 0.74703168 |
| 132 | MP0002971_abnormal_brown_adipose | 0.73604606 |
| 133 | MP0000703_abnormal_thymus_morphology | 0.73255796 |
| 134 | MP0001661_extended_life_span | 0.72898800 |
| 135 | MP0010329_abnormal_lipoprotein_level | 0.72158194 |
| 136 | MP0005166_decreased_susceptibility_to | 0.69556083 |
| 137 | MP0002098_abnormal_vibrissa_morphology | 0.69295185 |
| 138 | MP0001544_abnormal_cardiovascular_syste | 0.67775085 |
| 139 | MP0005385_cardiovascular_system_phenoty | 0.67775085 |
| 140 | MP0002998_abnormal_bone_remodeling | 0.67676641 |
| 141 | MP0004043_abnormal_pH_regulation | 0.66248494 |
| 142 | MP0005310_abnormal_salivary_gland | 0.65645816 |
| 143 | MP0009764_decreased_sensitivity_to | 0.65224138 |
| 144 | MP0000465_gastrointestinal_hemorrhage | 0.65121363 |
| 145 | MP0003191_abnormal_cellular_cholesterol | 0.64732109 |
| 146 | MP0001730_embryonic_growth_arrest | 0.64395449 |
| 147 | MP0008875_abnormal_xenobiotic_pharmacok | 0.63812267 |
| 148 | MP0005165_increased_susceptibility_to | 0.63350507 |
| 149 | MP0006035_abnormal_mitochondrial_morpho | 0.63307124 |
| 150 | MP0008260_abnormal_autophagy | 0.63197928 |
| 151 | MP0004484_altered_response_of | 0.62775548 |
| 152 | MP0003119_abnormal_digestive_system | 0.62211914 |
| 153 | MP0002396_abnormal_hematopoietic_system | 0.62030137 |
| 154 | MP0004197_abnormal_fetal_growth/weight/ | 0.61495706 |
| 155 | MP0003959_abnormal_lean_body | 0.60273200 |
| 156 | MP0002735_abnormal_chemical_nociception | 0.58258437 |
| 157 | MP0005501_abnormal_skin_physiology | 0.58052599 |
| 158 | MP0004142_abnormal_muscle_tone | 0.57999786 |
| 159 | MP0003183_abnormal_peptide_metabolism | 0.57664703 |
| 160 | MP0003795_abnormal_bone_structure | 0.56799581 |
| 161 | MP0010386_abnormal_urinary_bladder | 0.56716535 |
| 162 | MP0010030_abnormal_orbit_morphology | 0.56412411 |
| 163 | MP0002653_abnormal_ependyma_morphology | 0.54929379 |
| 164 | MP0005023_abnormal_wound_healing | 0.54025636 |
| 165 | MP0004782_abnormal_surfactant_physiolog | 0.51902129 |
| 166 | MP0004510_myositis | 0.51868891 |
| 167 | MP0009333_abnormal_splenocyte_physiolog | 0.51388608 |
| 168 | MP0004947_skin_inflammation | 0.51065741 |
| 169 | MP0004858_abnormal_nervous_system | 0.48976621 |
| 170 | MP0003984_embryonic_growth_retardation | 0.47642929 |
| 171 | MP0005376_homeostasis/metabolism_phenot | 0.47528926 |
| 172 | MP0010678_abnormal_skin_adnexa | 0.46653138 |
| 173 | MP0009697_abnormal_copulation | 0.46617930 |
| 174 | MP0001845_abnormal_inflammatory_respons | 0.46536337 |
| 175 | MP0000639_abnormal_adrenal_gland | 0.46252606 |
| 176 | MP0002088_abnormal_embryonic_growth/wei | 0.46183217 |
| 177 | MP0003638_abnormal_response/metabolism_ | 0.45574638 |
| 178 | MP0005448_abnormal_energy_balance | 0.44119141 |
| 179 | MP0001216_abnormal_epidermal_layer | 0.43411344 |
| 180 | MP0005220_abnormal_exocrine_pancreas | 0.42582824 |
| 181 | MP0000609_abnormal_liver_physiology | 0.41632503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 9.32064736 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 9.04529872 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.70522127 |
| 4 | Distal arthrogryposis (HP:0005684) | 7.71551994 |
| 5 | Posterior subcapsular cataract (HP:0007787) | 7.34958098 |
| 6 | Ventricular fibrillation (HP:0001663) | 7.16335386 |
| 7 | Congenital sensorineural hearing impairment (HP:0008527) | 6.63625153 |
| 8 | Type 1 muscle fiber predominance (HP:0003803) | 6.62509479 |
| 9 | Exercise-induced myalgia (HP:0003738) | 6.62194547 |
| 10 | Round ear (HP:0100830) | 5.98585578 |
| 11 | Myopathic facies (HP:0002058) | 5.90651644 |
| 12 | Right ventricular cardiomyopathy (HP:0011663) | 5.74572401 |
| 13 | Micronodular cirrhosis (HP:0001413) | 5.43358754 |
| 14 | Ulnar deviation of the wrist (HP:0003049) | 5.43191288 |
| 15 | Adrenal overactivity (HP:0002717) | 5.37738059 |
| 16 | Calcaneovalgus deformity (HP:0001848) | 5.33592277 |
| 17 | Late onset (HP:0003584) | 5.19450101 |
| 18 | Chorioretinal atrophy (HP:0000533) | 5.05833484 |
| 19 | Agammaglobulinemia (HP:0004432) | 5.02428371 |
| 20 | Exercise-induced muscle cramps (HP:0003710) | 5.01810334 |
| 21 | Deformed tarsal bones (HP:0008119) | 4.66388682 |
| 22 | Ketoacidosis (HP:0001993) | 4.65406254 |
| 23 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.40194845 |
| 24 | Abnormality of the pancreatic islet cells (HP:0006476) | 4.31817929 |
| 25 | Abnormality of endocrine pancreas physiology (HP:0012093) | 4.31817929 |
| 26 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.24849400 |
| 27 | Abdominal distention (HP:0003270) | 4.16664235 |
| 28 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.08005787 |
| 29 | Syncope (HP:0001279) | 4.04846408 |
| 30 | Esophageal varix (HP:0002040) | 4.04514495 |
| 31 | Calf muscle hypertrophy (HP:0008981) | 4.00727160 |
| 32 | EMG: myopathic abnormalities (HP:0003458) | 3.97458399 |
| 33 | Absent phalangeal crease (HP:0006109) | 3.88650678 |
| 34 | Malignant hyperthermia (HP:0002047) | 3.88471312 |
| 35 | Subcapsular cataract (HP:0000523) | 3.85068359 |
| 36 | Pili torti (HP:0003777) | 3.81436922 |
| 37 | Fetal akinesia sequence (HP:0001989) | 3.76999396 |
| 38 | Ileus (HP:0002595) | 3.73310933 |
| 39 | Neck muscle weakness (HP:0000467) | 3.71247757 |
| 40 | Muscle fiber splitting (HP:0003555) | 3.65150649 |
| 41 | Hyporeflexia of lower limbs (HP:0002600) | 3.44347286 |
| 42 | Popliteal pterygium (HP:0009756) | 3.41151187 |
| 43 | Multifactorial inheritance (HP:0001426) | 3.22864977 |
| 44 | Woolly hair (HP:0002224) | 3.17235756 |
| 45 | Increased variability in muscle fiber diameter (HP:0003557) | 3.13678404 |
| 46 | Abnormality of the calcaneus (HP:0008364) | 3.13286637 |
| 47 | Thin bony cortex (HP:0002753) | 3.11206718 |
| 48 | Rhabdomyolysis (HP:0003201) | 3.09093093 |
| 49 | Abnormal finger flexion creases (HP:0006143) | 3.08731650 |
| 50 | Insulin resistance (HP:0000855) | 3.08224571 |
| 51 | Myoglobinuria (HP:0002913) | 3.07202892 |
| 52 | Bulbar palsy (HP:0001283) | 3.06162089 |
| 53 | Abnormality of the calf musculature (HP:0001430) | 2.97012526 |
| 54 | Confusion (HP:0001289) | 2.96863524 |
| 55 | Type 2 muscle fiber atrophy (HP:0003554) | 2.94727989 |
| 56 | Difficulty running (HP:0009046) | 2.92866421 |
| 57 | Abnormal pancreas size (HP:0012094) | 2.92487980 |
| 58 | Rimmed vacuoles (HP:0003805) | 2.90105382 |
| 59 | Subaortic stenosis (HP:0001682) | 2.86739025 |
| 60 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.86739025 |
| 61 | Increased connective tissue (HP:0009025) | 2.86685319 |
| 62 | Ventricular arrhythmia (HP:0004308) | 2.86243194 |
| 63 | Muscle fiber atrophy (HP:0100295) | 2.84398194 |
| 64 | Weak cry (HP:0001612) | 2.82070356 |
| 65 | Autoimmune hemolytic anemia (HP:0001890) | 2.82047241 |
| 66 | Abnormality of vitamin B metabolism (HP:0004340) | 2.81386798 |
| 67 | Cellulitis (HP:0100658) | 2.76307624 |
| 68 | Prolonged QT interval (HP:0001657) | 2.72875452 |
| 69 | Palpitations (HP:0001962) | 2.71747706 |
| 70 | Muscle stiffness (HP:0003552) | 2.69791832 |
| 71 | Distal lower limb muscle weakness (HP:0009053) | 2.68824389 |
| 72 | Ketosis (HP:0001946) | 2.68535239 |
| 73 | Increased IgE level (HP:0003212) | 2.68087269 |
| 74 | Abnormality of B cell number (HP:0010975) | 2.62865237 |
| 75 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.60051423 |
| 76 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.59555445 |
| 77 | Frequent falls (HP:0002359) | 2.56797787 |
| 78 | Hypoglycemic coma (HP:0001325) | 2.55426864 |
| 79 | Growth hormone excess (HP:0000845) | 2.51303553 |
| 80 | Generalized muscle weakness (HP:0003324) | 2.49939812 |
| 81 | Hyperglycemia (HP:0003074) | 2.48187591 |
| 82 | Asymmetric septal hypertrophy (HP:0001670) | 2.46402751 |
| 83 | Abnormality of the neuromuscular junction (HP:0003398) | 2.45718755 |
| 84 | Fatigable weakness (HP:0003473) | 2.45718755 |
| 85 | Metatarsus adductus (HP:0001840) | 2.43802128 |
| 86 | EMG: neuropathic changes (HP:0003445) | 2.42090584 |
| 87 | Hip contracture (HP:0003273) | 2.39145449 |
| 88 | Hyperparathyroidism (HP:0000843) | 2.38670182 |
| 89 | B lymphocytopenia (HP:0010976) | 2.38342842 |
| 90 | Abnormality of vitamin metabolism (HP:0100508) | 2.37766571 |
| 91 | Mesangial abnormality (HP:0001966) | 2.33249415 |
| 92 | Abnormal hair laboratory examination (HP:0003328) | 2.27651917 |
| 93 | Trismus (HP:0000211) | 2.27106216 |
| 94 | Symptomatic seizures (HP:0011145) | 2.24754824 |
| 95 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.22729783 |
| 96 | Gowers sign (HP:0003391) | 2.22005512 |
| 97 | Conjunctival hamartoma (HP:0100780) | 2.21111413 |
| 98 | Hepatic necrosis (HP:0002605) | 2.21099029 |
| 99 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.20829642 |
| 100 | Areflexia of lower limbs (HP:0002522) | 2.20728077 |
| 101 | Myotonia (HP:0002486) | 2.19527881 |
| 102 | Biliary tract neoplasm (HP:0100574) | 2.18259563 |
| 103 | Amniotic constriction ring (HP:0009775) | 2.18213258 |
| 104 | Abnormality of placental membranes (HP:0011409) | 2.18213258 |
| 105 | Long clavicles (HP:0000890) | 2.17886856 |
| 106 | Abnormal EKG (HP:0003115) | 2.17561411 |
| 107 | Hyperammonemia (HP:0001987) | 2.16784075 |
| 108 | Recurrent pneumonia (HP:0006532) | 2.16654904 |
| 109 | Neoplasm of the rectum (HP:0100743) | 2.13972177 |
| 110 | Sudden death (HP:0001699) | 2.13735747 |
| 111 | Recurrent viral infections (HP:0004429) | 2.09694580 |
| 112 | Increased muscle lipid content (HP:0009058) | 2.09005610 |
| 113 | Easy fatigability (HP:0003388) | 2.08775808 |
| 114 | Selective tooth agenesis (HP:0001592) | 2.06696764 |
| 115 | Polar cataract (HP:0010696) | 2.04217535 |
| 116 | Meningitis (HP:0001287) | 2.02110318 |
| 117 | Limb-girdle muscle atrophy (HP:0003797) | 2.01065066 |
| 118 | Ankyloglossia (HP:0010296) | 2.00424132 |
| 119 | Hypercortisolism (HP:0001578) | 11.2886443 |
| 120 | Hepatocellular necrosis (HP:0001404) | 1.99845923 |
| 121 | Abnormality of the gastric mucosa (HP:0004295) | 1.99572069 |
| 122 | Alopecia of scalp (HP:0002293) | 1.99562735 |
| 123 | Bone cyst (HP:0012062) | 1.97520456 |
| 124 | Villous atrophy (HP:0011473) | 1.95203979 |
| 125 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.95203979 |
| 126 | Distal lower limb amyotrophy (HP:0008944) | 1.95200010 |
| 127 | Recurrent fungal infections (HP:0002841) | 1.94862984 |
| 128 | Neoplasm of the small intestine (HP:0100833) | 1.94791967 |
| 129 | Adducted thumb (HP:0001181) | 1.94419787 |
| 130 | Recurrent lower respiratory tract infections (HP:0002783) | 1.93821652 |
| 131 | Colitis (HP:0002583) | 1.93766135 |
| 132 | Lethargy (HP:0001254) | 1.93235043 |
| 133 | Recurrent cutaneous fungal infections (HP:0011370) | 1.93187820 |
| 134 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.93187820 |
| 135 | Aplasia of the musculature (HP:0100854) | 1.89721920 |
| 136 | Slender build (HP:0001533) | 1.89217022 |
| 137 | Sepsis (HP:0100806) | 1.88858241 |
| 138 | Polygenic inheritance (HP:0010982) | 1.86655010 |
| 139 | Abnormal biliary tract morphology (HP:0012440) | 1.85471249 |
| 140 | Dilated cardiomyopathy (HP:0001644) | 1.85277219 |
| 141 | Back pain (HP:0003418) | 1.83430876 |
| 142 | Thin ribs (HP:0000883) | 1.83046607 |
| 143 | Metaphyseal dysplasia (HP:0100255) | 1.82877102 |
| 144 | Lipid accumulation in hepatocytes (HP:0006561) | 1.82194891 |
| 145 | Pheochromocytoma (HP:0002666) | 1.81790673 |
| 146 | 11 pairs of ribs (HP:0000878) | 1.81616608 |
| 147 | Gastrointestinal inflammation (HP:0004386) | 1.80874972 |
| 148 | Inflammation of the large intestine (HP:0002037) | 1.79879672 |
| 149 | Eczematoid dermatitis (HP:0000976) | 1.78882104 |
| 150 | Cupped ribs (HP:0000887) | 1.77886585 |
| 151 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.77583503 |
| 152 | Waddling gait (HP:0002515) | 1.77274738 |
| 153 | Wide cranial sutures (HP:0010537) | 1.76944109 |
| 154 | Severe combined immunodeficiency (HP:0004430) | 1.75800195 |
| 155 | Pustule (HP:0200039) | 1.75274242 |
| 156 | Breech presentation (HP:0001623) | 1.75156559 |
| 157 | Mitochondrial inheritance (HP:0001427) | 1.74707025 |
| 158 | Sparse eyelashes (HP:0000653) | 1.74665162 |
| 159 | Increased intramyocellular lipid droplets (HP:0012240) | 1.74464814 |
| 160 | Autoimmune thrombocytopenia (HP:0001973) | 1.73592166 |
| 161 | Panhypogammaglobulinemia (HP:0003139) | 1.73229766 |
| 162 | Curly hair (HP:0002212) | 1.72995730 |
| 163 | Chronic sinusitis (HP:0011109) | 1.72044764 |
| 164 | Scapular winging (HP:0003691) | 1.71993340 |
| 165 | Abnormality of proline metabolism (HP:0010907) | 1.71474909 |
| 166 | Hydroxyprolinuria (HP:0003080) | 1.71474909 |
| 167 | Glycosuria (HP:0003076) | 1.70706318 |
| 168 | Abnormality of urine glucose concentration (HP:0011016) | 1.70706318 |
| 169 | Multiple enchondromatosis (HP:0005701) | 1.70681167 |
| 170 | Neuroendocrine neoplasm (HP:0100634) | 1.69301971 |
| 171 | Menstrual irregularities (HP:0000858) | 1.68799216 |
| 172 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.68142785 |
| 173 | Hyperuricemia (HP:0002149) | 1.67469908 |
| 174 | Increased purine levels (HP:0004368) | 1.67469908 |
| 175 | Ragged-red muscle fibers (HP:0003200) | 1.67408511 |
| 176 | Cerebral palsy (HP:0100021) | 1.67005433 |
| 177 | Osteomyelitis (HP:0002754) | 1.66984242 |
| 178 | Cardiomegaly (HP:0001640) | 1.66537019 |
| 179 | Delayed epiphyseal ossification (HP:0002663) | 1.64336857 |
| 180 | Protuberant abdomen (HP:0001538) | 1.63347669 |
| 181 | Hypercalcemia (HP:0003072) | 1.63122928 |
| 182 | Acute encephalopathy (HP:0006846) | 1.62883698 |
| 183 | Intestinal polyposis (HP:0200008) | 1.62233050 |
| 184 | Adenoma sebaceum (HP:0009720) | 1.61858065 |
| 185 | Angiofibromas (HP:0010615) | 1.61858065 |
| 186 | Dicarboxylic aciduria (HP:0003215) | 1.61316521 |
| 187 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.61316521 |
| 188 | Oral leukoplakia (HP:0002745) | 1.60959710 |
| 189 | Muscle fibrillation (HP:0010546) | 1.59505470 |
| 190 | Stenosis of the external auditory canal (HP:0000402) | 1.58845496 |
| 191 | Deep venous thrombosis (HP:0002625) | 1.53037139 |
| 192 | Progressive muscle weakness (HP:0003323) | 1.52802668 |
| 193 | Increased CSF lactate (HP:0002490) | 1.52542517 |
| 194 | Abnormality of purine metabolism (HP:0004352) | 1.49867816 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 7.17023279 |
| 2 | MAP2K2 | 4.53837409 |
| 3 | RPS6KB2 | 4.53289297 |
| 4 | NME1 | 4.45460496 |
| 5 | PIK3CG | 4.25713854 |
| 6 | TRIB3 | 3.73161821 |
| 7 | TTN | 3.56783693 |
| 8 | MAP2K6 | 3.35802535 |
| 9 | PKN2 | 3.17175515 |
| 10 | MAP4K1 | 3.01045673 |
| 11 | TESK2 | 2.96728921 |
| 12 | TYK2 | 2.84812880 |
| 13 | PHKG2 | 2.81871605 |
| 14 | PHKG1 | 2.81871605 |
| 15 | PTK6 | 2.58721065 |
| 16 | SCYL2 | 2.32710412 |
| 17 | NME2 | 2.25880500 |
| 18 | MAPK12 | 2.25336620 |
| 19 | MAP2K1 | 2.17067228 |
| 20 | IKBKE | 2.13704990 |
| 21 | PTK2 | 1.93934281 |
| 22 | MAP3K2 | 1.88646069 |
| 23 | PAK4 | 1.86084162 |
| 24 | MOS | 1.78219397 |
| 25 | MAPK15 | 1.75865692 |
| 26 | MAP3K3 | 1.74345610 |
| 27 | CDK8 | 1.74330411 |
| 28 | BUB1 | 1.72702618 |
| 29 | CAMK2B | 1.72500535 |
| 30 | KIT | 1.71604032 |
| 31 | MAP3K13 | 1.71311327 |
| 32 | ERN1 | 1.70591672 |
| 33 | PIM2 | 1.65690109 |
| 34 | PRKG2 | 1.63314053 |
| 35 | VRK2 | 1.61574828 |
| 36 | MAP3K10 | 1.61078812 |
| 37 | BLK | 1.60776156 |
| 38 | PLK4 | 1.58156921 |
| 39 | MAP3K11 | 1.57024476 |
| 40 | FRK | 1.55436868 |
| 41 | MUSK | 1.55435292 |
| 42 | MST4 | 1.54372873 |
| 43 | CAMK2D | 1.52426363 |
| 44 | TESK1 | 1.51649533 |
| 45 | LRRK2 | 1.43477293 |
| 46 | LMTK2 | 1.43001387 |
| 47 | CAMK2G | 1.38425164 |
| 48 | WNK3 | 1.38138372 |
| 49 | CSF1R | 1.33558653 |
| 50 | FER | 1.28364485 |
| 51 | KSR2 | 1.22253223 |
| 52 | RIPK4 | 1.16323885 |
| 53 | MAP3K7 | 1.15514756 |
| 54 | EPHA2 | 1.14255669 |
| 55 | FLT3 | 1.12118412 |
| 56 | TNK2 | 1.11245274 |
| 57 | MAP3K8 | 1.10323922 |
| 58 | MAP3K12 | 1.09474729 |
| 59 | DAPK2 | 1.08790673 |
| 60 | TBK1 | 1.07708701 |
| 61 | ILK | 1.07548208 |
| 62 | MAPKAPK3 | 1.05464949 |
| 63 | PRKCI | 1.05212366 |
| 64 | WNK4 | 1.03739126 |
| 65 | MST1R | 1.01679547 |
| 66 | SYK | 0.98494768 |
| 67 | LIMK1 | 0.94949653 |
| 68 | MAP2K3 | 0.94893568 |
| 69 | BCKDK | 0.92792925 |
| 70 | SIK1 | 0.90373599 |
| 71 | SIK3 | 0.88492554 |
| 72 | CDK19 | 0.87618999 |
| 73 | EPHB2 | 0.85922843 |
| 74 | MAP3K1 | 0.83857910 |
| 75 | PAK1 | 0.82543492 |
| 76 | TRPM7 | 0.78466135 |
| 77 | PRPF4B | 0.78266346 |
| 78 | MAPK7 | 0.78082958 |
| 79 | MET | 0.77794872 |
| 80 | ARAF | 0.77787885 |
| 81 | GRK6 | 0.74634125 |
| 82 | AKT2 | 0.72700357 |
| 83 | PDPK1 | 0.72032672 |
| 84 | STK10 | 0.71772527 |
| 85 | ERBB2 | 0.69245911 |
| 86 | KDR | 0.68959088 |
| 87 | BRAF | 0.68750591 |
| 88 | DYRK1B | 0.68100722 |
| 89 | NEK1 | 0.67810768 |
| 90 | HIPK2 | 0.67331984 |
| 91 | MAPKAPK5 | 0.65849067 |
| 92 | ZAP70 | 0.65792302 |
| 93 | DAPK1 | 0.64334383 |
| 94 | RAF1 | 0.64214277 |
| 95 | NEK9 | 0.62965335 |
| 96 | PINK1 | 0.62739153 |
| 97 | MATK | 0.61998348 |
| 98 | MARK2 | 0.61736272 |
| 99 | CLK1 | 0.61620256 |
| 100 | EEF2K | 0.61201891 |
| 101 | WEE1 | 0.60194788 |
| 102 | HCK | 0.58926962 |
| 103 | JAK3 | 0.57977009 |
| 104 | TAOK1 | 0.57923416 |
| 105 | EPHB1 | 0.57603646 |
| 106 | CDC42BPA | 0.57457019 |
| 107 | KSR1 | 0.56738621 |
| 108 | NEK2 | 0.53636674 |
| 109 | SIK2 | 0.53470750 |
| 110 | PAK3 | 0.53085926 |
| 111 | MAPK11 | 0.52794412 |
| 112 | RPS6KA4 | 0.51760787 |
| 113 | GRK7 | 0.51097847 |
| 114 | MAPKAPK2 | 0.50426266 |
| 115 | CCNB1 | 0.47307313 |
| 116 | MAPK4 | 0.46538993 |
| 117 | MAPK13 | 0.46130329 |
| 118 | RET | 0.45497715 |
| 119 | DMPK | 0.44264715 |
| 120 | TTK | 0.40915784 |
| 121 | PKN1 | 0.38507537 |
| 122 | CDK4 | 0.38325268 |
| 123 | TGFBR2 | 0.38282633 |
| 124 | LATS2 | 0.38235986 |
| 125 | PRKCQ | 0.38150562 |
| 126 | AURKB | 0.36933709 |
| 127 | SRC | 0.36385583 |
| 128 | IKBKB | 0.36267365 |
| 129 | CAMKK1 | 0.35667152 |
| 130 | FGFR4 | 0.35649827 |
| 131 | VRK1 | 0.35647470 |
| 132 | ROCK1 | 0.35169989 |
| 133 | ABL2 | 0.35121151 |
| 134 | BMPR2 | 0.34219820 |
| 135 | DAPK3 | 0.34180009 |
| 136 | PASK | 0.33366610 |
| 137 | CDK7 | 0.33352927 |
| 138 | RPS6KA1 | 0.33089597 |
| 139 | MYLK | 0.32494017 |
| 140 | CSNK1A1 | 0.32176764 |
| 141 | TEC | 0.32003010 |
| 142 | BMX | 0.31803972 |
| 143 | SMG1 | 0.31799934 |
| 144 | MARK3 | 0.31573050 |
| 145 | RIPK1 | 0.31158136 |
| 146 | LCK | 0.30878173 |
| 147 | PRKCA | 0.30629268 |
| 148 | LYN | 0.30582981 |
| 149 | AKT3 | 0.29788111 |
| 150 | BTK | 0.29688517 |
| 151 | ROCK2 | 0.29608791 |
| 152 | PDK1 | 0.28873373 |
| 153 | CSNK1E | 0.27996765 |
| 154 | IRAK4 | 0.27904648 |
| 155 | JAK2 | 0.27415113 |
| 156 | CSNK1D | 0.26960035 |
| 157 | JAK1 | 0.26713413 |
| 158 | CDK9 | 0.25925344 |
| 159 | PRKAA2 | 0.25545495 |
| 160 | PBK | 0.25180296 |
| 161 | EGFR | 0.24458850 |
| 162 | CDK15 | 0.24254628 |
| 163 | CAMK4 | 0.23801360 |
| 164 | CAMK2A | 0.23122352 |
| 165 | GSK3A | 0.22557188 |
| 166 | CSK | 0.22420470 |
| 167 | PRKCD | 0.21149288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 5.22200145 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.12034375 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.03331694 |
| 4 | Histidine metabolism_Homo sapiens_hsa00340 | 3.84897613 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.60979557 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.57133696 |
| 7 | Viral myocarditis_Homo sapiens_hsa05416 | 3.17682854 |
| 8 | Asthma_Homo sapiens_hsa05310 | 3.09042288 |
| 9 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 3.04636904 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.82944032 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.73391420 |
| 12 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.67751277 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.65354380 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.54536737 |
| 15 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.52445729 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.52419445 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.51339663 |
| 18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.48283159 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.44459304 |
| 20 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.34711334 |
| 21 | DNA replication_Homo sapiens_hsa03030 | 2.24229167 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.10395509 |
| 23 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.09122394 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.01464084 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.92850740 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.91925059 |
| 27 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.91045891 |
| 28 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.90600312 |
| 29 | Parkinsons disease_Homo sapiens_hsa05012 | 1.90437597 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.89949732 |
| 31 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.88976939 |
| 32 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.88370323 |
| 33 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.85113255 |
| 34 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.81539342 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.80548810 |
| 36 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.75846267 |
| 37 | Insulin secretion_Homo sapiens_hsa04911 | 1.75016304 |
| 38 | Leishmaniasis_Homo sapiens_hsa05140 | 1.64051940 |
| 39 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.62481657 |
| 40 | Base excision repair_Homo sapiens_hsa03410 | 1.61257509 |
| 41 | Tight junction_Homo sapiens_hsa04530 | 1.54430722 |
| 42 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.49650263 |
| 43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.48083837 |
| 44 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.45662333 |
| 45 | Galactose metabolism_Homo sapiens_hsa00052 | 1.44801130 |
| 46 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.44372458 |
| 47 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.43733548 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 1.43523697 |
| 49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.41132183 |
| 50 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.40957768 |
| 51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37571183 |
| 52 | Measles_Homo sapiens_hsa05162 | 1.33590142 |
| 53 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.29989718 |
| 54 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.23564695 |
| 55 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.23473730 |
| 56 | Proteasome_Homo sapiens_hsa03050 | 1.22909384 |
| 57 | Alzheimers disease_Homo sapiens_hsa05010 | 1.17824839 |
| 58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.17712333 |
| 59 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.16568707 |
| 60 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.14591150 |
| 61 | Huntingtons disease_Homo sapiens_hsa05016 | 1.13564207 |
| 62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.12765758 |
| 63 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.11851904 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.10123851 |
| 65 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.09922926 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 1.07480569 |
| 67 | Hepatitis C_Homo sapiens_hsa05160 | 1.05714420 |
| 68 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.00385025 |
| 69 | Bladder cancer_Homo sapiens_hsa05219 | 0.98205185 |
| 70 | Insulin resistance_Homo sapiens_hsa04931 | 0.97617058 |
| 71 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94466584 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.93643169 |
| 73 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.92252351 |
| 74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.90909167 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89831334 |
| 76 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.88357685 |
| 77 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.88199960 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87549234 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.86781399 |
| 80 | Carbon metabolism_Homo sapiens_hsa01200 | 0.86670136 |
| 81 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.85579901 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.85373599 |
| 83 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85018304 |
| 84 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.84899164 |
| 85 | Hepatitis B_Homo sapiens_hsa05161 | 0.82670317 |
| 86 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.80108198 |
| 87 | Lysine degradation_Homo sapiens_hsa00310 | 0.79080359 |
| 88 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.78837503 |
| 89 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.78726069 |
| 90 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.75054718 |
| 91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.73598929 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | 0.71261105 |
| 93 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.67890766 |
| 94 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.66055704 |
| 95 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.65729137 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64054344 |
| 97 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.61744261 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60535379 |
| 99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.60383565 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.59970987 |
| 101 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.59054909 |
| 102 | Bile secretion_Homo sapiens_hsa04976 | 0.58902754 |
| 103 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56800768 |
| 104 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54991459 |
| 105 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.54696625 |
| 106 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54169545 |
| 107 | Mineral absorption_Homo sapiens_hsa04978 | 0.54113937 |
| 108 | Salmonella infection_Homo sapiens_hsa05132 | 0.51379823 |
| 109 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.50616435 |
| 110 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.48486941 |
| 111 | Mismatch repair_Homo sapiens_hsa03430 | 0.46379288 |
| 112 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46234929 |
| 113 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.46190235 |
| 114 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.46149104 |
| 115 | Purine metabolism_Homo sapiens_hsa00230 | 0.45619059 |
| 116 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44570688 |
| 117 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44025005 |
| 118 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43408297 |
| 119 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.40691083 |
| 120 | Protein export_Homo sapiens_hsa03060 | 0.39935556 |
| 121 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.39474807 |
| 122 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39172105 |
| 123 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38532434 |
| 124 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.37582952 |
| 125 | Amoebiasis_Homo sapiens_hsa05146 | 0.36390155 |
| 126 | Shigellosis_Homo sapiens_hsa05131 | 0.36161515 |
| 127 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.35005645 |
| 128 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34276444 |
| 129 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.34106104 |
| 130 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.33558707 |
| 131 | Apoptosis_Homo sapiens_hsa04210 | 0.33076416 |
| 132 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.32641657 |
| 133 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.30979707 |
| 134 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29869139 |
| 135 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.29366111 |
| 136 | Pertussis_Homo sapiens_hsa05133 | 0.27836336 |
| 137 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.26930217 |
| 138 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.25900209 |
| 139 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.25807097 |
| 140 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.25639657 |
| 141 | Phagosome_Homo sapiens_hsa04145 | 0.25343748 |
| 142 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.24589809 |
| 143 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.24420173 |
| 144 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.24267338 |
| 145 | Other glycan degradation_Homo sapiens_hsa00511 | 0.23125756 |
| 146 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.22518228 |
| 147 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22087185 |
| 148 | Cocaine addiction_Homo sapiens_hsa05030 | 0.22069646 |
| 149 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.21891425 |
| 150 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.21620417 |
| 151 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.21266164 |
| 152 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.20699981 |
| 153 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.20400504 |
| 154 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.19979327 |
| 155 | Ribosome_Homo sapiens_hsa03010 | 0.19568772 |
| 156 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.18416352 |
| 157 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.16655447 |
| 158 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.15532397 |
| 159 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.13289219 |
| 160 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.13269900 |
| 161 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.12816040 |
| 162 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.12474222 |
| 163 | Influenza A_Homo sapiens_hsa05164 | 0.12358919 |
| 164 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.12171637 |
| 165 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.11422845 |
| 166 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.11379869 |
| 167 | Peroxisome_Homo sapiens_hsa04146 | 0.10976557 |
| 168 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.09181161 |
| 169 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.08154143 |
| 170 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.06309713 |

